ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei 
Welcome,         Profile    Billing    Logout  
 13 Diseases   0 Trials   0 Trials   14 News 
  • ||||||||||  ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
    Trial termination, Trial primary completion date:  An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome (clinicaltrials.gov) -  Mar 5, 2018   
    P3,  N=0, Terminated, 
    Recruiting --> Terminated | Trial primary completion date: Apr 2018 --> May 2017; Discontinuation of the development
  • ||||||||||  ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
    Trial completion, Trial primary completion date:  A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome (clinicaltrials.gov) -  Nov 18, 2017   
    P3,  N=0, Completed, 
    Recruiting --> Terminated | Trial primary completion date: Apr 2018 --> May 2017; Discontinuation of the development Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Oct 2017
  • ||||||||||  ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
    Trial completion, Trial primary completion date:  A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome (clinicaltrials.gov) -  May 17, 2017   
    P3,  N=0, Completed, 
    Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Oct 2017 Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Jan 2017
  • ||||||||||  ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
    Trial completion, Trial primary completion date:  A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes (clinicaltrials.gov) -  Oct 20, 2015   
    P2,  N=0, Completed, 
    Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Jan 2017 Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Mar 2014
  • ||||||||||  ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
    Enrollment closed:  A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes (clinicaltrials.gov) -  May 28, 2014   
    P2,  N=0, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Mar 2014 Recruiting --> Active, not recruiting
  • ||||||||||  ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
    Trial completion, P2 data:  A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome (clinicaltrials.gov) -  Oct 28, 2013   
    P2,  N=180, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed